As of 2025-06-17, the Intrinsic Value of Kezar Life Sciences Inc (KZR) is -42.46 USD. This KZR valuation is based on the model Peter Lynch Fair Value. With the current market price of 4.34 USD, the upside of Kezar Life Sciences Inc is -1,078.36%.
Based on its market price of 4.34 USD and our intrinsic valuation, Kezar Life Sciences Inc (KZR) is overvalued by 1,078.36%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -42.46 - -42.46 | -42.46 | -1,078.36% |
| P/E | (143.35) - (203.30) | (179.82) | -4243.4% |
| DDM - Stable | (76.81) - (271.95) | (174.38) | -4118.0% |
| DDM - Multi | (93.13) - (262.11) | (138.12) | -3282.5% |
| Market Cap (mil) | 31.73 |
| Beta | 0.94 |
| Outstanding shares (mil) | 7.31 |
| Enterprise Value (mil) | 3.81 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.27% |
| Cost of Debt | 5.00% |
| WACC | 7.96% |